Viewing nowRozarin Tablet (Losartan Potassium)
Losartan Potassium 50mg
Tablet · Prescription medication
iWorld Pharmaceutical Co., Ltd.

MFDS item code 200600104 · Notified 2006.01.09
This product's status changed to Expired on 2024.07.01. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of hypertension and nephropathy in patients with type 2 diabetes accompanied by hypertension
This medication is primarily used for the treatment of hypertension and is particularly helpful in preventing and managing kidney disease in patients with type 2 diabetes. It reduces the risk of cardiovascular complications associated with hypertension and contributes to the protection of kidney function. Therefore, this drug is effective in improving kidney problems caused by hypertension and diabetes.
This medicine may be taken with or without food, but it is recommended that it be taken at the same time each day. Hypertension — Adults: The recommended initial and maintenance dose is 50 mg of losartan potassium orally once daily. The maximum blood pressure-lowering effect is achieved 3 ∼ 6 weeks after starting treatment. If the therapeutic effect is insufficient, the same dose may be given orally in two divided doses daily, or the dose may be increased to 100 mg once daily if needed. Hypertension — If blood pressure is not controlled with this medicine alone, it may be used in combination with another antihypertensive agent (e.g., a low-dose diuretic). An additive effect has been observed when coadministered with hydrochlorothiazide. Nephropathy in patients with type 2 diabetes and hypertension: The usual adult dose is 50 mg of this medicine once daily. The dose may be increased to 100 mg once daily depending on blood pressure. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This medicine may be administered concomitantly with insulin and commonly used antihyperglycemic agents (e.g., sulfonylureas, glitazones, glucosidase inhibitors). Older adults: No adjustment of the initial dose is necessary in older adults aged 75 years or younger. For older adults over 75 years of age, an initial dose of 25 mg of this medicine once daily is recommended. Patients with renal impairment — Creatinine clearance 20 ∼ 50 mL/min: No adjustment of the initial dose is necessary. Patients with renal impairment — Creatinine clearance < 20 mL/min and patients on dialysis: An initial dose of 25 mg of this medicine once daily is recommended. Patients with reduced intravascular volume: An initial dose of 25 mg of this medicine once daily is recommended for patients who may have reduced intravascular volume (e.g., patients receiving diuretic therapy) (see Precautions for Use). Patients with hepatic impairment: A lower dose should be considered in patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.
Children and adolescents aged 6 years and older who weigh 20 kg or more but less than 50 kg and can swallow tablets: The recommended dose is 25 mg of this medicine once daily, which may be increased to a maximum of 50mg once daily depending on the patient's blood pressure response. Children and adolescents aged 6 years and older who weigh 50 kg or more: The usual recommended dose is 50 mg of this medicine once daily, which may be increased to a maximum of 100 mg once daily depending on the patient's blood pressure response. Pediatric patients under 6 years of age: Not recommended. Pediatric patients with a glomerular filtration rate below 30 mL/min/1.73㎡: Not recommended. Pediatric patients with hepatic impairment: Not recommended.
This medication can cause serious harm to the fetus if taken during pregnancy, particularly in the second and third trimesters, so it should be discontinued immediately upon confirmation of pregnancy. This drug should not be used in patients with severely impaired liver function, hereditary angioedema, or certain genetic lactose intolerance. Elderly patients or those with reduced kidney function or hyperkalemia should use this medication with caution, and care should be taken to avoid excessively low blood pressure. Patients taking this medication may experience dizziness or symptoms of low blood pressure, so caution is needed when driving or operating machinery. This drug can cause hyperkalemia, so it should not be taken with potassium supplements or potassium-containing salt substitutes, and serum potassium levels should be checked regularly. Additionally, this medication can affect liver or kidney function, so regular blood tests and physical examinations are necessary to monitor for any abnormalities. When taken with other antihypertensive agents or diuretics, the risk of hypotension or worsening of kidney function may increase, so it should be taken as directed by a physician. This medication may interact with certain antibiotics, analgesics, or lithium, so if other drugs are being taken, please consult a doctor or pharmacist. In case of overdose, blood pressure may drop sharply or heart rhythm may become irregular; if any unusual symptoms occur, seek medical attention immediately. Finally, keep this medication out of reach of children, and women who are pregnant or may become pregnant should consult a doctor before taking this medication.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and moisture, and it is best kept at room temperature between 1 to 30 degrees Celsius. By storing it this way, the efficacy of the medication can be maintained for a longer period.
White oval film-coated tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowLosartan Potassium 50mg
Tablet · Prescription medication
iWorld Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
DaeWon Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Korea United Pharm, Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
HK Inno.N Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
IYON Pharmaceuticals Co., Ltd.
Losartan Potassium
Prescription medication
JW ShinYak Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Kukje Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.